Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii

The Journal of Antimicrobial Chemotherapy
Paul G HigginsHarald Seifert

Abstract

To investigate the mechanism of ciprofloxacin resistance in isolates of Acinetobacter baumannii during two hospital outbreaks and to determine the expression level of the gene encoding the AdeB efflux pump. Isolates were previously typed by PFGE and their MICs determined by broth microdilution. The gyrA and parC genes were sequenced and the adeB gene examined by real-time reverse transcription PCR (RT-PCR). Two clonal lineages were responsible for the two hospital outbreaks. In both outbreaks, ciprofloxacin susceptibility was reduced during the course of the outbreak when compared with the index isolates. Mutations in gyrA and parC were found to have occurred during the outbreak. The MICs of non-fluoroquinolone antibiotics were raised in one clonal lineage and this was associated with a >10-fold increase in mRNA transcripts for adeB. We have witnessed the appearance of gyrA and parC mutations during outbreaks of A. baumannii. In parallel with these mutations, we observed up-regulation of the adeB gene associated with a decrease in susceptibility to non-fluoroquinolone antibiotics. These data illustrate the propensity for A. baumannii to develop multi-drug resistance rapidly.

References

Jun 1, 1997·The Journal of Antimicrobial Chemotherapy·J VilaT Jimenez de Anta
Aug 8, 1998·Annals of Internal Medicine·D VillersH Richet
Jun 29, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J G KoelemanP H Savelkoul
Mar 8, 2002·The New England Journal of Medicine·Ross DavidsonDonald E Low
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L Paterson

❮ Previous
Next ❯

Citations

May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D Curcio, F Fernández
May 5, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Alexey RuzinPatricia A Bradford
Jul 11, 2013·The Journal of Antimicrobial Chemotherapy·Lenka KrizovaAlexandr Nemec
Nov 26, 2008·Antimicrobial Agents and Chemotherapy·Alejandro BeceiroUNKNOWN Spanish Group for Nosocomial Infection (GEIH)
Apr 11, 2007·Antimicrobial Agents and Chemotherapy·Anton Y PelegDavid L Paterson
Dec 22, 2010·Antimicrobial Agents and Chemotherapy·Sébastien CoyneBruno Périchon
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Xian-Zhong SuTomofusa Tsuchiya
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Apr 15, 2006·Clinical Microbiology Reviews·Laura J V Piddock
Mar 20, 2009·Journal of Clinical Microbiology·Kristine M HujerRobert A Bonomo
Sep 8, 2005·Journal of Clinical Microbiology·Sergio G BartualFrancisco Rodríguez-Valera
Jul 23, 2011·Journal of Molecular Microbiology and Biotechnology·Bart A EijkelkampMelissa H Brown
Feb 24, 2011·BMC Genomics·Bart A EijkelkampMelissa H Brown
Aug 15, 2009·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Dec 6, 2008·Folia Histochemica Et Cytobiologica·Piotr WieczorekElzbieta Tryniszewska
Nov 19, 2014·Future Microbiology·Jessica M A BlairLaura J V Piddock
Jan 6, 2010·International Journal of Antimicrobial Agents·Nicola C Gordon, David W Wareham
Jan 1, 2009·Microbial Biotechnology·Anna FàbregaJordi Vila
Dec 25, 2012·Journal of Medical Microbiology·Yuki Yamada, Akira Suwabe
Mar 4, 2008·Expert Opinion on Pharmacotherapy·Jordi Vila, Jerónimo Pachón
Feb 10, 2011·The Annals of Pharmacotherapy·John EsterlyMarc H Scheetz
Oct 2, 2008·The Annals of Pharmacotherapy·Daniel Curcio
Oct 31, 2015·The Journal of Antimicrobial Chemotherapy·Felipe Fernández-CuencaUNKNOWN Spanish Group of Nosocomial Infections GEIH from the Spanish Society of Clinical Microbiology and Infectious Diseases SEIMC
Feb 3, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Derek S SarovichErin P Price
May 26, 2005·The Journal of Antimicrobial Chemotherapy·Keith Poole
Feb 28, 2007·The Journal of Antimicrobial Chemotherapy·Jordi VilaJavier Sánchez-Céspedes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.